AKT1 and Alzheimer disease: The weight of evidence suggests that mTOR activity is increased inthe temporal cortex and hippocampus of AD patients [295, 296], and an activated but dysregulated Akt/mTOR signallingpathway in the hippocampus would appear to be a universal feature of AD and MCI(reviewed by [297]).